French organization for the pharmacovigilance of COVID-19 vaccines: A major challengeClémence Lacroix, Joëlle Micallef, Nathalie Massy et al.|Therapies|2021Cited by 28
Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemicPauline Lory, Aurélie Grandvuillemin, Jeffrey Lombardi et al.|Therapies|2021Cited by 7